Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A side-by-side look at Sp 500 Equity and Multi Asset Retirement allocations, examining growth potential, risk, and diversification for retirement planning.
27,235 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
When you hear an insider just sold 10,000 shares, it triggers questions. This guide explains how to interpret such mo...
Cerebras Systems stock crashed after its latest earnings report, leaving investors asking what happened and what come...
What could SpaceX stock be worth by the end of 2026? This thoughtful guide weighs base, bullish, and bearish cases, p...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
New York City's education budget tops $42,000 per student in the 2027 proposal, the highest among large districts. Th...
Binance unveils a regional communications push, introduces new perpetual contracts, and plans to drop select trading ...
A fresh look at AI's impact on entry-level accounting roles shows higher turnover and a push for revamped onboarding ...
The FHA is reevaluating its anti-flipping rule while advancing automated valuation models, a move proponents say coul...
MARIS has launched a temporary fee waiver for new MLS subscribers, effective through late 2026, in a bid to simplify ...
Elon Musk asserts a breakthrough AI chip could outpace NVIDIA by 2-3x at a fraction of the cost, aiming for 2027 prod...
A top AI firm treads a thin line: warning about AI power while pushing new, powerful tools to market. This raises que...